Pricing Log in Create free account

MARKER THERAPEUTICS, INC. (MRKR) vs NewcelX Ltd. (NCEL)

MARKER THERAPEUTICS, INC. and NewcelX Ltd. are both Biotechnology companies. MARKER THERAPEUTICS, INC. and NewcelX Ltd. are of similar size ($15.3M and $15.3M). Across the 11 metrics below, NewcelX Ltd. leads on 6 and MARKER THERAPEUTICS, INC. on 5.

Valuation

Metric MRKR NCEL Biotechnology median
P/E n/m n/m 8.50
P/S 4.22 n/m 9.71
P/B 1.65 4.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.89 n/m 9.21
Earnings yield (39.42%) (61.20%) (33.15%)
Free cash flow yield (109.02%) (17.60%) (25.50%)

Profitability

Metric MRKR NCEL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.87%) 0.00% (56.36%)
Return on assets (59.33%) 0.00% (48.04%)
Return on invested capital (566.75%) 0.00% 0.00%

Growth

Metric MRKR NCEL Biotechnology median
Revenue growth (TTM) (27.83%) — 6.02%
EPS growth (last fiscal year) 33.61% 11.18% 30.26%
Revenue growth, 5-year CAGR 50.02% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRKR NCEL Biotechnology median
Debt to equity 0.07 0.06 0.00
Current ratio 6.03 0.40 4.72
Net debt to EBITDA 1.32 0.74 0.96

Dividend

Metric MRKR NCEL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MRKR NCEL Biotechnology median
Market cap 15.34m 15.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack